Fredrik Romi

2.9k total citations
47 papers, 2.0k citations indexed

About

Fredrik Romi is a scholar working on Neurology, Infectious Diseases and Surgery. According to data from OpenAlex, Fredrik Romi has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Neurology, 12 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Fredrik Romi's work include Myasthenia Gravis and Thymoma (38 papers), Peripheral Neuropathies and Disorders (29 papers) and Antifungal resistance and susceptibility (11 papers). Fredrik Romi is often cited by papers focused on Myasthenia Gravis and Thymoma (38 papers), Peripheral Neuropathies and Disorders (29 papers) and Antifungal resistance and susceptibility (11 papers). Fredrik Romi collaborates with scholars based in Norway, United Kingdom and United States. Fredrik Romi's co-authors include Nils Erik Gilhus, Geir Skeie, Johan A. Aarli, Jone Furlund Owe, Yu Hong, Paraskevi Zisimopoulou, Socrates J. Tzartos, Konstantinos Lazaridis, Halvor Næss and Anne Taraldsen Heldal and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Fredrik Romi

47 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fredrik Romi Norway 26 1.7k 450 255 156 140 47 2.0k
Huub Oosterhuis 2 1.6k 0.9× 340 0.8× 232 0.9× 149 1.0× 157 1.1× 2 1.8k
Naoki Kawaguchi Japan 22 996 0.6× 329 0.7× 122 0.5× 147 0.9× 75 0.5× 68 1.3k
John McConville United Kingdom 11 1.9k 1.1× 576 1.3× 191 0.7× 195 1.3× 79 0.6× 17 2.1k
Mariapaola Marino Italy 20 619 0.4× 274 0.6× 130 0.5× 223 1.4× 64 0.5× 70 1.3k
Flavia Scuderi Italy 19 585 0.3× 260 0.6× 111 0.4× 215 1.4× 65 0.5× 33 1.1k
Gary J. Hoffman United States 10 256 0.2× 114 0.3× 166 0.7× 176 1.1× 171 1.2× 13 895
Shigeki Kubo Japan 21 408 0.2× 76 0.2× 166 0.7× 231 1.5× 50 0.4× 62 979
P. Petiot France 13 509 0.3× 73 0.2× 81 0.3× 111 0.7× 72 0.5× 50 788
J. M. Bilbao Canada 17 391 0.2× 84 0.2× 166 0.7× 99 0.6× 54 0.4× 34 813
Benjamin J. Murdock United States 22 412 0.2× 240 0.5× 48 0.2× 298 1.9× 27 0.2× 28 1.2k

Countries citing papers authored by Fredrik Romi

Since Specialization
Citations

This map shows the geographic impact of Fredrik Romi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fredrik Romi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fredrik Romi more than expected).

Fields of papers citing papers by Fredrik Romi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fredrik Romi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fredrik Romi. The network helps show where Fredrik Romi may publish in the future.

Co-authorship network of co-authors of Fredrik Romi

This figure shows the co-authorship network connecting the top 25 collaborators of Fredrik Romi. A scholar is included among the top collaborators of Fredrik Romi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fredrik Romi. Fredrik Romi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romi, Fredrik, Yu Hong, & Nils Erik Gilhus. (2017). Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Current Opinion in Immunology. 49. 9–13. 51 indexed citations
2.
Romi, Fredrik & Halvor Næss. (2016). Spinal Cord Infarction in Clinical Neurology: A Review of Characteristics and Long-Term Prognosis in Comparison to Cerebral Infarction. European Neurology. 76(3-4). 95–98. 53 indexed citations
3.
Heldal, Anne Taraldsen, Geir Egil Eide, Fredrik Romi, Jone Furlund Owe, & Nils Erik Gilhus. (2014). Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development. PLoS ONE. 9(12). e114060–e114060. 44 indexed citations
4.
Romi, Fredrik, et al.. (2012). Serum Levels of Matrix Metalloproteinases: Implications in Clinical Neurology. European Neurology. 67(2). 121–128. 65 indexed citations
5.
Romi, Fredrik, Shigeaki Suzuki, Norihiro Suzuki, et al.. (2011). Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis. Journal of Neurology. 259(7). 1312–1316. 55 indexed citations
6.
Romi, Fredrik, et al.. (2011). Heat-Shock Proteins in Clinical Neurology. European Neurology. 66(2). 65–69. 21 indexed citations
7.
Romi, Fredrik & Halvor Næss. (2011). Characteristics of Spinal Cord Stroke in Clinical Neurology. European Neurology. 66(5). 305–309. 14 indexed citations
8.
Heldal, Anne Taraldsen, Geir Egil Eide, Nils Erik Gilhus, & Fredrik Romi. (2011). Geographical distribution of A seropositive myasthenia gravis population. Muscle & Nerve. 45(6). 815–819. 21 indexed citations
9.
Petzold, Axel, et al.. (2011). Matrix Metalloproteinases in Myasthenia Gravis. European Neurology. 65(1). 53–58. 16 indexed citations
10.
Owe, Jone Furlund, Milada Cvancarova, Fredrik Romi, & Nils Erik Gilhus. (2010). Extrathymic malignancies in thymoma patients with and without myasthenia gravis. Journal of the Neurological Sciences. 290(1-2). 66–69. 26 indexed citations
11.
Skeie, Geir & Fredrik Romi. (2008). Paraneoplastic myasthenia gravis: immunological and clinical aspects. European Journal of Neurology. 15(10). 1029–1033. 53 indexed citations
12.
Romi, Fredrik, Nils Erik Gilhus, & Steven P. Luckman. (2008). Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis. Journal of Neuroimmunology. 195(1-2). 96–99. 10 indexed citations
13.
Romi, Fredrik, Einar K. Kristoffersen, Johan A. Aarli, & Nils Erik Gilhus. (2004). The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo. Journal of Neuroimmunology. 158(1-2). 191–194. 52 indexed citations
14.
Agius, Mark, David P. Richman, Robert H. Fairclough, et al.. (2003). Three Forms of Immune Myasthenia. Annals of the New York Academy of Sciences. 998(1). 453–456. 10 indexed citations
15.
Romi, Fredrik, Nils Erik Gilhus, Jan Erik Varhaug, Andreas O. Myking, & Johan A. Aarli. (2003). Disease severity and outcome in thymoma myasthenia gravis: a long‐term observation study. European Journal of Neurology. 10(6). 701–706. 38 indexed citations
16.
Skeie, Geir, et al.. (2003). Pathogenesis of Myositis and Myasthenia Associated with Titin and Ryanodine Receptor Antibodies. Annals of the New York Academy of Sciences. 998(1). 343–350. 22 indexed citations
17.
Romi, Fredrik, Lars Eirik Bø, Geir Skeie, et al.. (2002). Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. Journal of Neuroimmunology. 128(1-2). 82–89. 51 indexed citations
18.
Romi, Fredrik, Nils Erik Gilhus, Jan Erik Varhaug, et al.. (2002). Thymectomy and anti‐muscle autoantibodies in late‐onset myasthenia gravis. European Journal of Neurology. 9(1). 55–61. 30 indexed citations
19.
Romi, Fredrik, et al.. (2000). [Diffusion-weighted magnetic resonance tomography--a new instrument in the diagnosis of Creutzfeldt-Jakob disease].. PubMed. 120(6). 675–7. 2 indexed citations
20.
Romi, Fredrik, Geir Skeie, Johan A. Aarli, & Nils Erik Gilhus. (2000). The Severity of Myasthenia Gravis Correlates With the Serum Concentration of Titin and Ryanodine Receptor Antibodies. Archives of Neurology. 57(11). 1596–600. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huub Oosterhuis Breakdown of academic impact, for papers by Naoki Kawaguchi Breakdown of academic impact, for papers by John McConville Breakdown of academic impact, for papers by Mariapaola Marino Breakdown of academic impact, for papers by Flavia Scuderi Breakdown of academic impact, for papers by Gary J. Hoffman Breakdown of academic impact, for papers by Shigeki Kubo Breakdown of academic impact, for papers by P. Petiot Breakdown of academic impact, for papers by J. M. Bilbao Breakdown of academic impact, for papers by Benjamin J. Murdock
Rankless by CCL
2026